The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study

1. Martínez-López, J.
2. Mustjoki, S.
3. Porkka, K.
4. Klisovic, R.B.
5. Wolf, D.
6. Busque, L.
7. Hernández-Boluda, J.C.
8. Swanink, R.
9. Martin Regueira, P.
10. Lipton, J.H.